Synthetic bryostatin analogues activate the RasGRP1 signaling pathway

Journal article

Peer reviewed

James C Stone, Stacey L Stang, YONG Zheng, Nancy A Dower, Stacey E Brenner, Jeremy L Baryza and Paul A Wender

Journal of medicinal chemistry, Vol.47(26), pp.6638-6644

2004

PMID: 15588099

Abstract

Antineoplastic agents

Biological and medical sciences

General aspects

Immunomodulators

Medical sciences

Pharmacology. Drug treatments

12 Record Views

Title: Synthetic bryostatin analogues activate the RasGRP1 signaling pathway
Creators: James C Stone - Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
Stacey L Stang - Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
YONG Zheng - Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
Nancy A Dower - Department of Pediatrics, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
Stacey E Brenner - Department of Chemistry, Stanford University, Stanford, California 94305, United States
Jeremy L Baryza - Department of Chemistry, Stanford University, Stanford, California 94305, United States
Paul A Wender - Department of Chemistry, Stanford University, Stanford, California 94305, United States
Publication Details: Journal of medicinal chemistry, Vol.47(26), pp.6638-6644
Date published: 2004
Publisher: American Chemical Society
Academic Unit: Chemistry (SASN)
Language: English
Resource Type: Journal article
Identifiers: 991031666268104646